A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis

NCT06989645 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of Knee

Interventions

DRUG: SYN321
DRUG: Placebo

Sponsor

Synartro AB

Collaborators

[object Object]